Brief: Opdivo Plus Yervoy Reimbursed Under Ontario's Fast Program As First-Line Treatment For Advanced Liver Cancer
03/02/2026 13:08
Feb 3 (Reuters) - Bristol-Myers Squibb Co BMY.N: OPDIVO® PLUS YERVOY® REIMBURSED UNDER ONTARIO'S FAST PROGRAM AS FIRST-LINE TREATMENT FOR ADVANCED LIVER CANCER Source text: ID:nCNWYmPSza Further company coverage: BMY.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb Co
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: Bristol Myers Squibb Announces Dividend
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Izalontamab Brengitecan Shows Significant OS And PFS Improvements In TNBC And ESCC